↓ Skip to main content

Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin

Overview of attention for article published in JAMA: Journal of the American Medical Association, March 2008
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Readers on

mendeley
174 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Published in
JAMA: Journal of the American Medical Association, March 2008
DOI 10.1001/jama.299.9.1036
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 4 2%
Netherlands 2 1%
United Kingdom 2 1%
Spain 1 <1%
Canada 1 <1%
Argentina 1 <1%
Unknown 163 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 29 17%
Student > Master 25 14%
Student > Bachelor 18 10%
Student > Ph. D. Student 13 7%
Professor > Associate Professor 13 7%
Other 43 25%
Unknown 33 19%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 79 45%
Agricultural and Biological Sciences 12 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Biochemistry, Genetics and Molecular Biology 6 3%
Psychology 6 3%
Other 23 13%
Unknown 41 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 344. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2022.
All research outputs
#120,341
of 34,360,889 outputs
Outputs from JAMA: Journal of the American Medical Association
#1,899
of 42,270 outputs
Outputs of similar age
#178
of 136,061 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#2
of 141 outputs
Altmetric has tracked 34,360,889 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,270 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 73.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,061 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.